Brought to you by 
Molecular diagnostics company CareDx nets $8.4mm in FOPO
27 Sep 2016
Executive Summary
CareDx Inc. (molecular diagnostics for transplant patients) netted $8.4mm in a follow-on public offering of 2.25mm common shares at $4. Earlier in the year the company raised additional funds in a private placement to support its acquisition of Allenex AB. The company will use the proceeds to support the continued development of AlloSure for a clinical utility trial and commercialization.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Molecular diagnostics company CareDx nets $8.4mm in FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice